Ther­mo Fish­er con­tin­ues its hot streak, but a dip in di­ag­nos­tics sales could be trou­ble

Dur­ing Ther­mo Fish­er Sci­en­tif­ic’s Q1 call back in April, an­a­lysts were con­cerned whether the com­pa­ny’s suc­cess was sus­tain­able with rev­enue growth of 137% on the year — large­ly thanks to its Covid-19 di­ag­nos­tics busi­ness.

At least in the short term, those fears have yet to come to bear.

Ther­mo Fish­er’s rev­enue in­creased an­oth­er 34% to $9.27 bil­lion in Q2 with $1.9 bil­lion of that linked to US  de­mand for its di­ag­nos­tics.. All 80,000 em­ploy­ees are set to re­ceive an ad­di­tion­al two weeks pay as a re­sult of the strong fi­nan­cial re­sults.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER